Trying to improve the compliance to colorectal cancer screening: A complex study design for a complex planning question

Contemporary Clinical Trials

Volumn 26, Issue 3, 2005, Pages 323-330

  Rossi, Paolo Giorgi ^a   Federici, Antonio ^a   Bartolozzi, Francesco ^b   Farchi, Sara ^a   Borgia, Piero ^a   Guasticchi, Gabriella ^a  

^a Agency for Public Health   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Cluster randomisation; Colorectal cancer; Compliance; Factorial design; Faecal occult blood test; Screening

Indexed keywords

ANTICOAGULANT AGENT;

ACCURACY; CANCER SCREENING; CASE CONTROL STUDY; CLINICAL TRIAL; COLORECTAL CANCER; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; REVIEW;

EID: 19444372687     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2005.01.005     Document Type: Article

References (23)

1. B. Towler, L. Irwig, and P. Glasziou A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test Hemoccult. BMJ 317 7158 1998 (August 29) 559 565
2. S.J. Blalock, B.M. DeVellis, and R.S. Sandler Participation in fecal occult blood screening: a critical review Prev. Med. 16 1 1987 (Jan) 9 18
3. V. Box, S. Nichols, R.C. Lallemand, P. Pearson, and P.A. Vakil Haemoccult compliance rates and reasons for non-compliance Public Health 98 1 1984 (Jan) 16 25
4. P.A. Farrands, J.D. Hardcastle, J. Chamberlain, and S. Moss Factors affecting compliance with screening for colorectal cancer Community Med. 6 1 1984 (Feb) 12 19
5. Jepson R, Clegg A, Forbes C, et al. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess 2000;4(14):i-vii, 1-133.
6. P.D. Greenberg, L. Bertario, and R. Gnauck A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy Am. J. Gastroenterol. 95 2000 1331 1338
7. O. Kronborg, C. Fenger, J. Olsen, O.D. Jorgensen, and O. Sondergaard Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 1996 1467 1471
8. J.E. Allison, I.S. Tekawa, L.J. Ransom, and A.L. Adrain A comparison of fecal occult-blood tests for colorectal-cancer screening N. Engl. J. Med. 334 1996 155 159
9. H. Miyoshi, M. Oka, and K. Sugi Accuracy of detection of colorectal neoplasia using an immunochemical occult blood test in symptomatic referred patients: comparison of retrospective and prospective studies Intern. Med. 39 2000 701 706
10. G.P. Young, D.J. St John, S.J. Winawer, and P. Rozen WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report Am. J. Gastroenterol. 97 10 2002 (Oct) 2499 2507
11. E. Lindholm, B. Berglund, E. Haglind, and J. Kewenter Factors associated with participation in screening for colorectal cancer with faecal occult blood testing Scand. J. Gastroenterol. 30 2 1995 (Feb) 171 176
12. American Gastroenterological Association Colorectal cancer screening: clinical guidelines and rationale Gastroenterology 112 1997 594 642
13. G. Pye, M. Christie, J.O. Chamberlain, S.M. Moss, and J.D. Hardcastle A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload J. Epidemiol. Community Health 42 1 1988 (Mar) 66 71
14. A. Grassi Tracking regional endoscopy activity Gastrointest. Endosc. 55 2002 298 300
15. C.N. Klabunde, P.S. Frame, and A. Meadow A national survey of primary care physicians' colorectal cancer screening recommendations and practices Prev. Med. 36 3 2003 (Mar) 352 362
16. Stata Corporation Stata statistical software: release 7.0 2001 Stata Corporation College Station, TX
17. Epi-data Freeware, Epidata software: release v2.1, Dec 2001 [cited, 5 April 2004], http://www.epidata.dk/index.htm.
18. N. Segnan, C. Senore, and B. Andreoni SCORE Working Group-Italy. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"-SCORE J. Natl. Cancer Inst. 94 23 2002 (Dec 4) 1763 1772
19. F.Y. Hsieh Sample size formulae for intervention studies with the cluster as unit of randomization Stat. Med. 7 11 1988 (Nov) 1195 1201 [Erratum in: Stat Med Jun 15. 16(11) (1997) 1300]
20. R.H. Cosby, M. Howard, J. Kaczorowski, A.R. Willan, and J.W. Sellors Randomizing patients by family practice: sample size estimation, intracluster correlation and data analysis Fam. Pract. 20 1 2003 (Feb) 77 82
21. N. Klar, and A. Donner Current and future challenges in the design and analysis of cluster randomization trials Stat. Med. 20 24 2001 (Dec 30) 3729 3740
22. O.C. Ukoumunne, M.C. Gulliford, S. Chinn, J.A.C. Sterne, and P.G.J. Burney Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review Health Technol. Assess. 3 1999 1 98
23. N.B. Baskerville, W. Hogg, and J. Lemelin The effect of cluster randomization on sample size in prevention research J.P. Famract. 50 3 2001 (Mar) W241 W246